Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
20 Aug 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/breaking-down-dual-track-strategy-behind-iterums-launch-first-new-uncomplicated-uti-drug
26 Oct 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-iterums-treatment-urinary-infection-2024-10-25/
06 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/fda-concerned-iterums-urinary-tract-infection-drug-could-cause-antimicrobial-resistance
30 Jan 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/iterum-therapeutics-announces-positive-topline-results-from-its-phase-3-reassure-clinical-trial-of-oral-sulopenem-in-uncomplicated-urinary-tract-infections-302047483.html
11 Jan 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/01/11/2587531/0/en/Iterum-Therapeutics-Reports-Employment-Inducement-Grant.html
15 Dec 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/12/15/2574503/0/en/Iterum-Therapeutics-announces-Issuance-of-Allowance-for-a-U-S-Patent-Covering-Oral-Sulopenem.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE